RTI Surgical Insider-Eigentum
Was ist das Insider-Eigentum von RTI Surgical?
Insider-Eigentum von RTI Surgical Holdings, Inc. ist 11.17%
Was ist die Definition von Insider-Eigentum?
Das Insider-Eigentum wird berechnet als die Gesamtzahl der Aktien, die sich im Besitz von Insidern (Anteilseignern, die mehr als 5% der Gesellschaft oder eines leitenden Angestellten oder Direktors der Gesellschaft besitzen), dividiert durch die Gesamtzahl der ausstehenden Aktien.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider-Eigentum von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu RTI Surgical
Was macht RTI Surgical?
RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.
Unternehmen mit insider-eigentum ähnlich RTI Surgical
- Huntsman Exploration Inc hat Insider-Eigentum von 11.14%
- BlueBird Battery Metals hat Insider-Eigentum von 11.14%
- China e-Wallet Payment hat Insider-Eigentum von 11.14%
- Integral Diagnostics hat Insider-Eigentum von 11.15%
- QinetiQ plc hat Insider-Eigentum von 11.15%
- Lonestar Resources US hat Insider-Eigentum von 11.15%
- RTI Surgical hat Insider-Eigentum von 11.17%
- The Star Entertainment hat Insider-Eigentum von 11.17%
- Dixie hat Insider-Eigentum von 11.17%
- SoFi Technologies hat Insider-Eigentum von 11.18%
- Sanofi hat Insider-Eigentum von 11.18%
- Sanofi hat Insider-Eigentum von 11.18%
- Corcept Therapeutics Inc hat Insider-Eigentum von 11.18%